To provide that the provision of the Medicare Program: Hospital Outpatient Prospective Payment and Ambulatory Surgical Center Payment Systems and Quality Reporting Programs final regulation relating to changes in the payment amount for certain drugs and biologicals purchased under the 340B drug discount program shall have no force or effect, and for other purposes.

Cost and committee reports

Official records Congress.gov attaches to H.R. 4392.

• Constitutional authority statementThe sponsor’s statement of where the Constitution gives Congress the power to pass this bill. Statement by Mr. McKINLEY, as printed in the Congressional Record (Vol. 163, No. 186, November 14, 2017, Page H9255):
  According to Article I, Section 8, Clause 3 of the Constitution: The Congress shall have power to enact this legislation to regulate commerce with foreign nations, and among the several states, and with the Indian tribes.
  Source: Congress.gov, Congressional Record November 14, 2017 ↗

  Evidence

  Field in the Congress.gov record

  constitutionalAuthorityStatementText

  Statement length

  221 characters

  Congress.gov bill record

  H.R. 4392, 115th Congress

  Congress.gov API record

  https://api.congress.gov/v3/bill/115/hr/4392

  Record last updated by Congress.gov

  April 7, 2025

  PORKER copy retrieved

  September 21, 2026

  Stored copy, SHA-256 of the file

  3958b2e9f8f33094725b9745ee7b3d41edac537bd90cb47ab3cf9e27dc22255e

  PORKER shows the statement exactly as printed, with the page markup removed. It is the sponsor’s claim; it is not a legal finding.

Congress.gov’s record for this bill does not list a CBO cost estimate or a committee report (as of April 7, 2025). Not every bill gets one.

From the Congress.gov bill record for H.R. 4392, last updated April 7, 2025. PORKER’s copy was retrieved September 21, 2026 and is refreshed nightly. Open “Evidence” on any line for the record, field and file fingerprint.